|
🐜
|
Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies
46 auth.
W. Williams,
H. Liao,
M. A. Moody,
T. Kepler,
S. Alam,
F. Gao,
K. Wiehe,
Ashley Trama,
K. Jones,
Ruijun Zhang,
Hongshuo Song,
Dawn J. Marshall,
J. Whitesides,
Kaitlin Sawatzki,
A. Hua,
...
Pinghuang Liu,
M. Tay,
K. Seaton,
Xiaoying Shen,
A. Foulger,
Krissey E. Lloyd,
R. Parks,
J. Pollara,
G. Ferrari,
J. Yu,
N. Vandergrift,
D. Montefiori,
M. Sobieszczyk,
S. Hammer,
S. Karuna,
P. Gilbert,
D. Grove,
N. Grunenberg,
M. McElrath,
J. Mascola,
R. Koup,
L. Corey,
G. Nabel,
C. Morgan,
G. Churchyard,
J. Maenza,
M. Keefer,
B. Graham,
L. Baden,
G. Tomaras,
B. Haynes
|
7 |
2015 |
7
🐜
|
|
🐜
|
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120/MF59 in Adults
61 auth.
G. Gray,
L. Bekker,
F. Laher,
M. Malahleha,
M. Allen,
Z. Moodie,
N. Grunenberg,
Yunda Huang,
D. Grove,
Brittany Prigmore,
J. J. Kee,
D. Benkeser,
J. Hural,
C. Innes,
E. Lazarus,
...
G. Meintjes,
N. Naicker,
Dishiki Kalonji,
M. Nchabeleng,
M. Sebe,
Nishanta Singh,
P. Kotze,
S. Kassim,
T. Dubula,
Vimla Naicker,
W. Brumskine,
Cleon N Ncayiya,
A. Ward,
N. Garrett,
Girisha Kistnasami,
Z. Gaffoor,
P. Selepe,
P. Makhoba,
M. Mathebula,
P. Mda,
Tania Adonis,
K. Mapetla,
Bontle Modibedi,
T. Philip,
Gladys Kobane,
Carter Bentley,
S. Ramirez,
Simbarashe Takuva,
Megan Jones,
M. Sikhosana,
M. Atujuna,
M. Andrasik,
N. Hejazi,
A. Puren,
L. Wiesner,
S. Phogat,
C. D. Diaz Granados,
M. Koutsoukos,
Olivier Van Der Meeren,
S. Barnett,
N. Kanesa-Thasan,
J. Kublin,
M. McElrath,
P. Gilbert,
H. Janes,
L. Corey
|
7 |
2021 |
7
🐜
|
|
🐜
|
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
23 auth.
K. Mayer,
K. Seaton,
Yunda Huang,
N. Grunenberg,
Abby Isaacs,
M. Allen,
J. Ledgerwood,
I. Frank,
M. Sobieszczyk,
L. Baden,
...
B. Rodriguez,
Hong Van Tieu,
G. Tomaras,
A. Deal,
D. Goodman,
R. Bailer,
G. Ferrari,
Ryan Jensen,
J. Hural,
B. Graham,
J. Mascola,
L. Corey,
D. Montefiori
|
6 |
2017 |
6
🐜
|
|
🐜
|
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
34 auth.
L. Bekker,
Z. Moodie,
N. Grunenberg,
F. Laher,
G. Tomaras,
Kristen W. Cohen,
M. Allen,
M. Malahleha,
K. Mngadi,
B. Daniels,
C. Innes,
Carter Bentley,
N. Frahm,
D. Morris,
L. Morris,
...
N. Mkhize,
D. Montefiori,
M. Sarzotti-Kelsoe,
S. Grant,
Chenchen Yu,
V. Mehra,
M. Pensiero,
S. Phogat,
C. Diazgranados,
S. Barnett,
N. Kanesa-Thasan,
M. Koutsoukos,
N. Michael,
M. Robb,
J. Kublin,
P. Gilbert,
L. Corey,
G. Gray,
M. McElrath
|
6 |
2018 |
6
🐜
|
|
🐜
|
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
93 auth.
L. Baden,
L. Baden,
L. Baden,
E. Karita,
E. Karita,
E. Karita,
G. Mutua,
G. Mutua,
G. Mutua,
L. Bekker,
L. Bekker,
L. Bekker,
G. Gray,
G. Gray,
G. Gray,
...
L. Page-Shipp,
L. Page-Shipp,
L. Page-Shipp,
S. Walsh,
S. Walsh,
S. Walsh,
J. Nyombayire,
J. Nyombayire,
J. Nyombayire,
O. Anzala,
O. Anzala,
O. Anzala,
S. Roux,
S. Roux,
S. Roux,
F. Laher,
F. Laher,
F. Laher,
C. Innes,
C. Innes,
C. Innes,
M. Seaman,
M. Seaman,
M. Seaman,
Yehuda Z. Cohen,
Yehuda Z. Cohen,
Yehuda Z. Cohen,
Lauren Peter,
Lauren Peter,
Lauren Peter,
N. Frahm,
N. Frahm,
N. Frahm,
M. McElrath,
M. McElrath,
M. McElrath,
P. Hayes,
P. Hayes,
P. Hayes,
E. Swann,
E. Swann,
E. Swann,
N. Grunenberg,
N. Grunenberg,
N. Grunenberg,
Maria Grazia-Pau,
Maria Grazia-Pau,
Maria Grazia-Pau,
M. Weijtens,
M. Weijtens,
M. Weijtens,
J. Sadoff,
J. Sadoff,
J. Sadoff,
L. Dally,
L. Dally,
L. Dally,
Angela Lombardo,
Angela Lombardo,
Angela Lombardo,
J. Gilmour,
J. Gilmour,
J. Gilmour,
J. Cox,
J. Cox,
J. Cox,
R. Dolin,
R. Dolin,
R. Dolin,
P. Fast,
P. Fast,
P. Fast,
D. Barouch,
D. Barouch,
D. Barouch,
D. Laufer,
D. Laufer,
D. Laufer
|
6 |
2016 |
6
🐜
|
|
🐜
|
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
93 auth.
L. Baden,
L. Baden,
L. Baden,
E. Karita,
E. Karita,
E. Karita,
G. Mutua,
G. Mutua,
G. Mutua,
L. Bekker,
L. Bekker,
L. Bekker,
G. Gray,
G. Gray,
G. Gray,
...
L. Page-Shipp,
L. Page-Shipp,
L. Page-Shipp,
S. Walsh,
S. Walsh,
S. Walsh,
J. Nyombayire,
J. Nyombayire,
J. Nyombayire,
O. Anzala,
O. Anzala,
O. Anzala,
S. Roux,
S. Roux,
S. Roux,
F. Laher,
F. Laher,
F. Laher,
C. Innes,
C. Innes,
C. Innes,
M. Seaman,
M. Seaman,
M. Seaman,
Yehuda Z. Cohen,
Yehuda Z. Cohen,
Yehuda Z. Cohen,
Lauren Peter,
Lauren Peter,
Lauren Peter,
N. Frahm,
N. Frahm,
N. Frahm,
M. McElrath,
M. McElrath,
M. McElrath,
P. Hayes,
P. Hayes,
P. Hayes,
E. Swann,
E. Swann,
E. Swann,
N. Grunenberg,
N. Grunenberg,
N. Grunenberg,
Maria Grazia-Pau,
Maria Grazia-Pau,
Maria Grazia-Pau,
M. Weijtens,
M. Weijtens,
M. Weijtens,
J. Sadoff,
J. Sadoff,
J. Sadoff,
L. Dally,
L. Dally,
L. Dally,
Angela Lombardo,
Angela Lombardo,
Angela Lombardo,
J. Gilmour,
J. Gilmour,
J. Gilmour,
J. Cox,
J. Cox,
J. Cox,
R. Dolin,
R. Dolin,
R. Dolin,
P. Fast,
P. Fast,
P. Fast,
D. Barouch,
D. Barouch,
D. Barouch,
D. Laufer,
D. Laufer,
D. Laufer
|
6 |
2016 |
6
🐜
|
|
🐜
|
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
93 auth.
L. Baden,
L. Baden,
L. Baden,
E. Karita,
E. Karita,
E. Karita,
G. Mutua,
G. Mutua,
G. Mutua,
L. Bekker,
L. Bekker,
L. Bekker,
G. Gray,
G. Gray,
G. Gray,
...
L. Page-Shipp,
L. Page-Shipp,
L. Page-Shipp,
S. Walsh,
S. Walsh,
S. Walsh,
J. Nyombayire,
J. Nyombayire,
J. Nyombayire,
O. Anzala,
O. Anzala,
O. Anzala,
S. Roux,
S. Roux,
S. Roux,
F. Laher,
F. Laher,
F. Laher,
C. Innes,
C. Innes,
C. Innes,
M. Seaman,
M. Seaman,
M. Seaman,
Yehuda Z. Cohen,
Yehuda Z. Cohen,
Yehuda Z. Cohen,
Lauren Peter,
Lauren Peter,
Lauren Peter,
N. Frahm,
N. Frahm,
N. Frahm,
M. McElrath,
M. McElrath,
M. McElrath,
P. Hayes,
P. Hayes,
P. Hayes,
E. Swann,
E. Swann,
E. Swann,
N. Grunenberg,
N. Grunenberg,
N. Grunenberg,
Maria Grazia-Pau,
Maria Grazia-Pau,
Maria Grazia-Pau,
M. Weijtens,
M. Weijtens,
M. Weijtens,
J. Sadoff,
J. Sadoff,
J. Sadoff,
L. Dally,
L. Dally,
L. Dally,
Angela Lombardo,
Angela Lombardo,
Angela Lombardo,
J. Gilmour,
J. Gilmour,
J. Gilmour,
J. Cox,
J. Cox,
J. Cox,
R. Dolin,
R. Dolin,
R. Dolin,
P. Fast,
P. Fast,
P. Fast,
D. Barouch,
D. Barouch,
D. Barouch,
D. Laufer,
D. Laufer,
D. Laufer
|
6 |
2016 |
6
🐜
|
|
🐜
|
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa
36 auth.
Glenda E Gray,
Glenda E Gray,
Glenda E Gray,
Ying Huang,
N. Grunenberg,
F. Laher,
S. Roux,
E. Andersen-Nissen,
Stephen C. De Rosa,
B. Flach,
A. Randhawa,
Ryan Jensen,
E. Swann,
L. Bekker,
C. Innes,
...
E. Lazarus,
L. Morris,
N. Mkhize,
G. Ferrari,
D. Montefiori,
Xiaoying Shen,
Sheetal S Sawant,
N. Yates,
J. Hural,
Abby Isaacs,
S. Phogat,
C. Diazgranados,
Carter Lee,
F. Sinangil,
N. Michael,
M. Robb,
J. Kublin,
P. Gilbert,
M. McElrath,
G. Tomaras,
L. Corey
|
5 |
2019 |
5
🐜
|
|
🐜
|
Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults
11 auth.
Yunda Huang,
Lily Zhang,
J. Ledgerwood,
N. Grunenberg,
R. Bailer,
Abby Isaacs,
...
K. Seaton,
K. Mayer,
E. Capparelli,
L. Corey,
P. Gilbert
|
5 |
2017 |
5
🐜
|
